Appointments at Cadence Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Cadence Pharmaceuticals (US) has appointed Dr Todd Rich to the company's board of directors and named Malcolm Lloyd-Smith senior vice-president of regulatory affairs and quality assurance. Mr Lloyd-Smith assumes the role previously held by Malvina Laudicina, who resigned from the company; he was previously vice-president and head of global regulatory affairs at Elan Pharmaceuticals. Dr Rich is vice-president of development regulatory, medical information, drug safety, quality and compliance at Genentech.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.